Global Topical Drug Delivery

Topical Drug Delivery Comprehensive Study by Type (Skin Topical Drug Delivery , Ophthalmic Topical Drug Delivery , Rectal Topical Drug Delivery , Vaginal Topical Drug Delivery , Nasal Topical Drug Delivery, Others), Application (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Others), Components (Transdermal Drug Delivery Systems, Topical Drug Delivery Formulations), Form (Creams, Gels, Powder, Skin Patches, Others) Players and Region - Global Market Outlook to 2027

Topical Drug Delivery Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The topical drug delivery is the application of formulations to the skin directly for the treatment of cutaneous disorders or manifestation of general disease. It is done with the intent confining the pharmacological effects of the drug within the skin or on the surface of the skin. The industrial sector for topical drug delivery is growing rapidly in addition to the established transdermal formulations by a large number of manufacturing companies. The global topical drug delivery market is constantly expanding throughout the world with a prevalence of skin-related diseases.This growth is primarily driven by Prevalence of Skin Diseases in People Across the Globe and Growing Demand for Topical Medications and Therapies.

Globally, a noticeable market trend is evident Demand From Asia Pacific for Topical Drug Delivery is Rising . Major Players, such as GlaxoSmithKline plc (United Kingdom), Johnson & Johnson (United States), Novartis International AG (Switzerland), Galderma S.A. (Switzerland), Bausch Health Companies Inc. (Canada), Easton Pharmaceuticals, Inc. (Canada), Bayer AG (Germany), The 3M Company (United States), Endo International plc (United States), Crescita Therapeutics Inc (Canada), MedPharm Ltd. (United Kingdom) and Catalent, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Regulatory Insights:
"The US Food and Drug Administration (FDA) on 20th November 2019 issued draft guidance detailing product development and quality considerations for transdermal and topical delivery systems (TDS) for new and generic drugs. FDA says that both systems present similar manufacturing and quality control concerns and similar risks to patients, and mostly fall into one of two categories: matrix type and liquid or gel reservoir type delivery systems. FDA notes that the guidance may not apply to other types of TDS, such as microneedles, active transport TDS or TDS applied to broken skin and advises applicants to focus on matrix type TDS due to inherent failure modes and safety risks associated with reservoir TDS."

Market Drivers
  • Prevalence of Skin Diseases in People Across the Globe
  • Growing Demand for Topical Medications and Therapies

Market Trend
  • Demand From Asia Pacific for Topical Drug Delivery is Rising
  • Increasing Use of Semi-Solid Formulation of Drugs

Restraints
  • Stringent Regulatory Guidelines on Topical Drug Delivery
  • Allergies Associated with Topical Drug Delivery

Opportunities
The Popularity of Topical Formulations in Pharmaceutical Topical Drug Delivery and Surging Number of Dermatologists Across the World will Boost the Topical Drug Delivery Market
Challenges
Threats of Substitutes Due to Various Low Priced Products

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Topical Drug Delivery Study Sheds Light on
— The Topical Drug Delivery Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Topical Drug Delivery industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Topical Drug Delivery industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Skin Topical Drug Delivery 
  • Ophthalmic Topical Drug Delivery 
  • Rectal Topical Drug Delivery 
  • Vaginal Topical Drug Delivery 
  • Nasal Topical Drug Delivery
  • Others
By Application
  • Hospitals
  • Home Healthcare
  • Clinics
  • Diagnostic Centers
  • Others
By Components
  • Transdermal Drug Delivery Systems
  • Topical Drug Delivery Formulations

By Form
  • Creams
  • Gels
  • Powder
  • Skin Patches
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Skin Diseases in People Across the Globe
      • 3.2.2. Growing Demand for Topical Medications and Therapies
    • 3.3. Market Challenges
      • 3.3.1. Threats of Substitutes Due to Various Low Priced Products
    • 3.4. Market Trends
      • 3.4.1. Demand From Asia Pacific for Topical Drug Delivery is Rising
      • 3.4.2. Increasing Use of Semi-Solid Formulation of Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Topical Drug Delivery, by Type, Application, Components, Form and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Topical Drug Delivery (Value)
      • 5.2.1. Global Topical Drug Delivery by: Type (Value)
        • 5.2.1.1. Skin Topical Drug Delivery 
        • 5.2.1.2. Ophthalmic Topical Drug Delivery 
        • 5.2.1.3. Rectal Topical Drug Delivery 
        • 5.2.1.4. Vaginal Topical Drug Delivery 
        • 5.2.1.5. Nasal Topical Drug Delivery
        • 5.2.1.6. Others
      • 5.2.2. Global Topical Drug Delivery by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Home Healthcare
        • 5.2.2.3. Clinics
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Others
      • 5.2.3. Global Topical Drug Delivery by: Components (Value)
        • 5.2.3.1. Transdermal Drug Delivery Systems
        • 5.2.3.2. Topical Drug Delivery Formulations
      • 5.2.4. Global Topical Drug Delivery by: Form (Value)
        • 5.2.4.1. Creams
        • 5.2.4.2. Gels
        • 5.2.4.3. Powder
        • 5.2.4.4. Skin Patches
        • 5.2.4.5. Others
      • 5.2.5. Global Topical Drug Delivery Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Topical Drug Delivery (Volume)
      • 5.3.1. Global Topical Drug Delivery by: Type (Volume)
        • 5.3.1.1. Skin Topical Drug Delivery 
        • 5.3.1.2. Ophthalmic Topical Drug Delivery 
        • 5.3.1.3. Rectal Topical Drug Delivery 
        • 5.3.1.4. Vaginal Topical Drug Delivery 
        • 5.3.1.5. Nasal Topical Drug Delivery
        • 5.3.1.6. Others
      • 5.3.2. Global Topical Drug Delivery by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Home Healthcare
        • 5.3.2.3. Clinics
        • 5.3.2.4. Diagnostic Centers
        • 5.3.2.5. Others
      • 5.3.3. Global Topical Drug Delivery by: Components (Volume)
        • 5.3.3.1. Transdermal Drug Delivery Systems
        • 5.3.3.2. Topical Drug Delivery Formulations
      • 5.3.4. Global Topical Drug Delivery by: Form (Volume)
        • 5.3.4.1. Creams
        • 5.3.4.2. Gels
        • 5.3.4.3. Powder
        • 5.3.4.4. Skin Patches
        • 5.3.4.5. Others
      • 5.3.5. Global Topical Drug Delivery Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Topical Drug Delivery (Price)
      • 5.4.1. Global Topical Drug Delivery by: Type (Price)
  • 6. Topical Drug Delivery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis International AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Galderma S.A. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bausch Health Companies Inc. (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Easton Pharmaceuticals, Inc. (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. The 3M Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Endo International plc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Crescita Therapeutics Inc (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. MedPharm Ltd. (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Catalent, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Topical Drug Delivery Sale, by Type, Application, Components, Form and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Topical Drug Delivery (Value)
      • 7.2.1. Global Topical Drug Delivery by: Type (Value)
        • 7.2.1.1. Skin Topical Drug Delivery 
        • 7.2.1.2. Ophthalmic Topical Drug Delivery 
        • 7.2.1.3. Rectal Topical Drug Delivery 
        • 7.2.1.4. Vaginal Topical Drug Delivery 
        • 7.2.1.5. Nasal Topical Drug Delivery
        • 7.2.1.6. Others
      • 7.2.2. Global Topical Drug Delivery by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Home Healthcare
        • 7.2.2.3. Clinics
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Others
      • 7.2.3. Global Topical Drug Delivery by: Components (Value)
        • 7.2.3.1. Transdermal Drug Delivery Systems
        • 7.2.3.2. Topical Drug Delivery Formulations
      • 7.2.4. Global Topical Drug Delivery by: Form (Value)
        • 7.2.4.1. Creams
        • 7.2.4.2. Gels
        • 7.2.4.3. Powder
        • 7.2.4.4. Skin Patches
        • 7.2.4.5. Others
      • 7.2.5. Global Topical Drug Delivery Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Topical Drug Delivery (Volume)
      • 7.3.1. Global Topical Drug Delivery by: Type (Volume)
        • 7.3.1.1. Skin Topical Drug Delivery 
        • 7.3.1.2. Ophthalmic Topical Drug Delivery 
        • 7.3.1.3. Rectal Topical Drug Delivery 
        • 7.3.1.4. Vaginal Topical Drug Delivery 
        • 7.3.1.5. Nasal Topical Drug Delivery
        • 7.3.1.6. Others
      • 7.3.2. Global Topical Drug Delivery by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Home Healthcare
        • 7.3.2.3. Clinics
        • 7.3.2.4. Diagnostic Centers
        • 7.3.2.5. Others
      • 7.3.3. Global Topical Drug Delivery by: Components (Volume)
        • 7.3.3.1. Transdermal Drug Delivery Systems
        • 7.3.3.2. Topical Drug Delivery Formulations
      • 7.3.4. Global Topical Drug Delivery by: Form (Volume)
        • 7.3.4.1. Creams
        • 7.3.4.2. Gels
        • 7.3.4.3. Powder
        • 7.3.4.4. Skin Patches
        • 7.3.4.5. Others
      • 7.3.5. Global Topical Drug Delivery Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Topical Drug Delivery (Price)
      • 7.4.1. Global Topical Drug Delivery by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Topical Drug Delivery: by Type(USD Million)
  • Table 2. Topical Drug Delivery Skin Topical Drug Delivery  , by Region USD Million (2016-2021)
  • Table 3. Topical Drug Delivery Ophthalmic Topical Drug Delivery  , by Region USD Million (2016-2021)
  • Table 4. Topical Drug Delivery Rectal Topical Drug Delivery  , by Region USD Million (2016-2021)
  • Table 5. Topical Drug Delivery Vaginal Topical Drug Delivery  , by Region USD Million (2016-2021)
  • Table 6. Topical Drug Delivery Nasal Topical Drug Delivery , by Region USD Million (2016-2021)
  • Table 7. Topical Drug Delivery Others , by Region USD Million (2016-2021)
  • Table 8. Topical Drug Delivery: by Application(USD Million)
  • Table 9. Topical Drug Delivery Hospitals , by Region USD Million (2016-2021)
  • Table 10. Topical Drug Delivery Home Healthcare , by Region USD Million (2016-2021)
  • Table 11. Topical Drug Delivery Clinics , by Region USD Million (2016-2021)
  • Table 12. Topical Drug Delivery Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 13. Topical Drug Delivery Others , by Region USD Million (2016-2021)
  • Table 14. Topical Drug Delivery: by Components(USD Million)
  • Table 15. Topical Drug Delivery Transdermal Drug Delivery Systems , by Region USD Million (2016-2021)
  • Table 16. Topical Drug Delivery Topical Drug Delivery Formulations , by Region USD Million (2016-2021)
  • Table 17. Topical Drug Delivery: by Form(USD Million)
  • Table 18. Topical Drug Delivery Creams , by Region USD Million (2016-2021)
  • Table 19. Topical Drug Delivery Gels , by Region USD Million (2016-2021)
  • Table 20. Topical Drug Delivery Powder , by Region USD Million (2016-2021)
  • Table 21. Topical Drug Delivery Skin Patches , by Region USD Million (2016-2021)
  • Table 22. Topical Drug Delivery Others , by Region USD Million (2016-2021)
  • Table 23. South America Topical Drug Delivery, by Country USD Million (2016-2021)
  • Table 24. South America Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 25. South America Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 26. South America Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 27. South America Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 28. Brazil Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 29. Brazil Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 30. Brazil Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 31. Brazil Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 32. Argentina Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 33. Argentina Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 34. Argentina Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 35. Argentina Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 36. Rest of South America Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 37. Rest of South America Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 38. Rest of South America Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 39. Rest of South America Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 40. Asia Pacific Topical Drug Delivery, by Country USD Million (2016-2021)
  • Table 41. Asia Pacific Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 42. Asia Pacific Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 43. Asia Pacific Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 44. Asia Pacific Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 45. China Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 46. China Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 47. China Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 48. China Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 49. Japan Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 50. Japan Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 51. Japan Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 52. Japan Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 53. India Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 54. India Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 55. India Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 56. India Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 57. South Korea Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 58. South Korea Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 59. South Korea Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 60. South Korea Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 61. Taiwan Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 62. Taiwan Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 63. Taiwan Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 64. Taiwan Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 65. Australia Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 66. Australia Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 67. Australia Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 68. Australia Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 72. Rest of Asia-Pacific Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 73. Europe Topical Drug Delivery, by Country USD Million (2016-2021)
  • Table 74. Europe Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 75. Europe Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 76. Europe Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 77. Europe Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 78. Germany Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 79. Germany Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 80. Germany Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 81. Germany Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 82. France Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 83. France Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 84. France Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 85. France Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 86. Italy Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 87. Italy Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 88. Italy Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 89. Italy Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 90. United Kingdom Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 91. United Kingdom Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 92. United Kingdom Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 93. United Kingdom Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 94. Netherlands Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 95. Netherlands Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 96. Netherlands Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 97. Netherlands Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 98. Rest of Europe Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 99. Rest of Europe Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 100. Rest of Europe Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 101. Rest of Europe Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 102. MEA Topical Drug Delivery, by Country USD Million (2016-2021)
  • Table 103. MEA Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 104. MEA Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 105. MEA Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 106. MEA Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 107. Middle East Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 108. Middle East Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 109. Middle East Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 110. Middle East Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 111. Africa Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 112. Africa Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 113. Africa Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 114. Africa Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 115. North America Topical Drug Delivery, by Country USD Million (2016-2021)
  • Table 116. North America Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 117. North America Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 118. North America Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 119. North America Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 120. United States Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 121. United States Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 122. United States Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 123. United States Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 124. Canada Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 125. Canada Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 126. Canada Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 127. Canada Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 128. Mexico Topical Drug Delivery, by Type USD Million (2016-2021)
  • Table 129. Mexico Topical Drug Delivery, by Application USD Million (2016-2021)
  • Table 130. Mexico Topical Drug Delivery, by Components USD Million (2016-2021)
  • Table 131. Mexico Topical Drug Delivery, by Form USD Million (2016-2021)
  • Table 132. Topical Drug Delivery Sales: by Type(K Units)
  • Table 133. Topical Drug Delivery Sales Skin Topical Drug Delivery  , by Region K Units (2016-2021)
  • Table 134. Topical Drug Delivery Sales Ophthalmic Topical Drug Delivery  , by Region K Units (2016-2021)
  • Table 135. Topical Drug Delivery Sales Rectal Topical Drug Delivery  , by Region K Units (2016-2021)
  • Table 136. Topical Drug Delivery Sales Vaginal Topical Drug Delivery  , by Region K Units (2016-2021)
  • Table 137. Topical Drug Delivery Sales Nasal Topical Drug Delivery , by Region K Units (2016-2021)
  • Table 138. Topical Drug Delivery Sales Others , by Region K Units (2016-2021)
  • Table 139. Topical Drug Delivery Sales: by Application(K Units)
  • Table 140. Topical Drug Delivery Sales Hospitals , by Region K Units (2016-2021)
  • Table 141. Topical Drug Delivery Sales Home Healthcare , by Region K Units (2016-2021)
  • Table 142. Topical Drug Delivery Sales Clinics , by Region K Units (2016-2021)
  • Table 143. Topical Drug Delivery Sales Diagnostic Centers , by Region K Units (2016-2021)
  • Table 144. Topical Drug Delivery Sales Others , by Region K Units (2016-2021)
  • Table 145. Topical Drug Delivery Sales: by Components(K Units)
  • Table 146. Topical Drug Delivery Sales Transdermal Drug Delivery Systems , by Region K Units (2016-2021)
  • Table 147. Topical Drug Delivery Sales Topical Drug Delivery Formulations , by Region K Units (2016-2021)
  • Table 148. Topical Drug Delivery Sales: by Form(K Units)
  • Table 149. Topical Drug Delivery Sales Creams , by Region K Units (2016-2021)
  • Table 150. Topical Drug Delivery Sales Gels , by Region K Units (2016-2021)
  • Table 151. Topical Drug Delivery Sales Powder , by Region K Units (2016-2021)
  • Table 152. Topical Drug Delivery Sales Skin Patches , by Region K Units (2016-2021)
  • Table 153. Topical Drug Delivery Sales Others , by Region K Units (2016-2021)
  • Table 154. South America Topical Drug Delivery Sales, by Country K Units (2016-2021)
  • Table 155. South America Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 156. South America Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 157. South America Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 158. South America Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 159. Brazil Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 160. Brazil Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 161. Brazil Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 162. Brazil Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 163. Argentina Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 164. Argentina Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 165. Argentina Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 166. Argentina Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 167. Rest of South America Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 168. Rest of South America Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 169. Rest of South America Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 170. Rest of South America Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 171. Asia Pacific Topical Drug Delivery Sales, by Country K Units (2016-2021)
  • Table 172. Asia Pacific Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 173. Asia Pacific Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 174. Asia Pacific Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 175. Asia Pacific Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 176. China Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 177. China Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 178. China Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 179. China Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 180. Japan Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 181. Japan Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 182. Japan Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 183. Japan Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 184. India Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 185. India Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 186. India Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 187. India Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 188. South Korea Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 189. South Korea Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 190. South Korea Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 191. South Korea Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 192. Taiwan Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 193. Taiwan Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 194. Taiwan Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 195. Taiwan Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 196. Australia Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 197. Australia Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 198. Australia Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 199. Australia Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 200. Rest of Asia-Pacific Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 201. Rest of Asia-Pacific Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 202. Rest of Asia-Pacific Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 203. Rest of Asia-Pacific Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 204. Europe Topical Drug Delivery Sales, by Country K Units (2016-2021)
  • Table 205. Europe Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 206. Europe Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 207. Europe Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 208. Europe Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 209. Germany Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 210. Germany Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 211. Germany Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 212. Germany Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 213. France Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 214. France Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 215. France Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 216. France Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 217. Italy Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 218. Italy Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 219. Italy Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 220. Italy Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 221. United Kingdom Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 222. United Kingdom Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 223. United Kingdom Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 224. United Kingdom Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 225. Netherlands Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 226. Netherlands Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 227. Netherlands Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 228. Netherlands Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 229. Rest of Europe Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 230. Rest of Europe Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 231. Rest of Europe Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 232. Rest of Europe Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 233. MEA Topical Drug Delivery Sales, by Country K Units (2016-2021)
  • Table 234. MEA Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 235. MEA Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 236. MEA Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 237. MEA Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 238. Middle East Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 239. Middle East Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 240. Middle East Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 241. Middle East Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 242. Africa Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 243. Africa Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 244. Africa Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 245. Africa Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 246. North America Topical Drug Delivery Sales, by Country K Units (2016-2021)
  • Table 247. North America Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 248. North America Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 249. North America Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 250. North America Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 251. United States Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 252. United States Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 253. United States Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 254. United States Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 255. Canada Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 256. Canada Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 257. Canada Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 258. Canada Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 259. Mexico Topical Drug Delivery Sales, by Type K Units (2016-2021)
  • Table 260. Mexico Topical Drug Delivery Sales, by Application K Units (2016-2021)
  • Table 261. Mexico Topical Drug Delivery Sales, by Components K Units (2016-2021)
  • Table 262. Mexico Topical Drug Delivery Sales, by Form K Units (2016-2021)
  • Table 263. Topical Drug Delivery: by Type(USD/Units)
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Topical Drug Delivery: by Type(USD Million)
  • Table 277. Topical Drug Delivery Skin Topical Drug Delivery  , by Region USD Million (2022-2027)
  • Table 278. Topical Drug Delivery Ophthalmic Topical Drug Delivery  , by Region USD Million (2022-2027)
  • Table 279. Topical Drug Delivery Rectal Topical Drug Delivery  , by Region USD Million (2022-2027)
  • Table 280. Topical Drug Delivery Vaginal Topical Drug Delivery  , by Region USD Million (2022-2027)
  • Table 281. Topical Drug Delivery Nasal Topical Drug Delivery , by Region USD Million (2022-2027)
  • Table 282. Topical Drug Delivery Others , by Region USD Million (2022-2027)
  • Table 283. Topical Drug Delivery: by Application(USD Million)
  • Table 284. Topical Drug Delivery Hospitals , by Region USD Million (2022-2027)
  • Table 285. Topical Drug Delivery Home Healthcare , by Region USD Million (2022-2027)
  • Table 286. Topical Drug Delivery Clinics , by Region USD Million (2022-2027)
  • Table 287. Topical Drug Delivery Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 288. Topical Drug Delivery Others , by Region USD Million (2022-2027)
  • Table 289. Topical Drug Delivery: by Components(USD Million)
  • Table 290. Topical Drug Delivery Transdermal Drug Delivery Systems , by Region USD Million (2022-2027)
  • Table 291. Topical Drug Delivery Topical Drug Delivery Formulations , by Region USD Million (2022-2027)
  • Table 292. Topical Drug Delivery: by Form(USD Million)
  • Table 293. Topical Drug Delivery Creams , by Region USD Million (2022-2027)
  • Table 294. Topical Drug Delivery Gels , by Region USD Million (2022-2027)
  • Table 295. Topical Drug Delivery Powder , by Region USD Million (2022-2027)
  • Table 296. Topical Drug Delivery Skin Patches , by Region USD Million (2022-2027)
  • Table 297. Topical Drug Delivery Others , by Region USD Million (2022-2027)
  • Table 298. South America Topical Drug Delivery, by Country USD Million (2022-2027)
  • Table 299. South America Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 300. South America Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 301. South America Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 302. South America Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 303. Brazil Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 304. Brazil Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 305. Brazil Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 306. Brazil Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 307. Argentina Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 308. Argentina Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 309. Argentina Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 310. Argentina Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 311. Rest of South America Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 312. Rest of South America Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 313. Rest of South America Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 314. Rest of South America Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 315. Asia Pacific Topical Drug Delivery, by Country USD Million (2022-2027)
  • Table 316. Asia Pacific Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 317. Asia Pacific Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 318. Asia Pacific Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 319. Asia Pacific Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 320. China Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 321. China Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 322. China Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 323. China Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 324. Japan Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 325. Japan Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 326. Japan Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 327. Japan Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 328. India Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 329. India Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 330. India Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 331. India Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 332. South Korea Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 333. South Korea Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 334. South Korea Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 335. South Korea Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 336. Taiwan Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 337. Taiwan Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 338. Taiwan Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 339. Taiwan Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 340. Australia Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 341. Australia Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 342. Australia Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 343. Australia Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 344. Rest of Asia-Pacific Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 345. Rest of Asia-Pacific Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 346. Rest of Asia-Pacific Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 347. Rest of Asia-Pacific Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 348. Europe Topical Drug Delivery, by Country USD Million (2022-2027)
  • Table 349. Europe Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 350. Europe Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 351. Europe Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 352. Europe Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 353. Germany Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 354. Germany Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 355. Germany Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 356. Germany Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 357. France Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 358. France Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 359. France Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 360. France Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 361. Italy Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 362. Italy Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 363. Italy Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 364. Italy Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 365. United Kingdom Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 366. United Kingdom Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 367. United Kingdom Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 368. United Kingdom Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 369. Netherlands Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 370. Netherlands Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 371. Netherlands Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 372. Netherlands Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 373. Rest of Europe Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 374. Rest of Europe Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 375. Rest of Europe Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 376. Rest of Europe Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 377. MEA Topical Drug Delivery, by Country USD Million (2022-2027)
  • Table 378. MEA Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 379. MEA Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 380. MEA Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 381. MEA Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 382. Middle East Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 383. Middle East Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 384. Middle East Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 385. Middle East Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 386. Africa Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 387. Africa Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 388. Africa Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 389. Africa Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 390. North America Topical Drug Delivery, by Country USD Million (2022-2027)
  • Table 391. North America Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 392. North America Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 393. North America Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 394. North America Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 395. United States Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 396. United States Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 397. United States Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 398. United States Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 399. Canada Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 400. Canada Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 401. Canada Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 402. Canada Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 403. Mexico Topical Drug Delivery, by Type USD Million (2022-2027)
  • Table 404. Mexico Topical Drug Delivery, by Application USD Million (2022-2027)
  • Table 405. Mexico Topical Drug Delivery, by Components USD Million (2022-2027)
  • Table 406. Mexico Topical Drug Delivery, by Form USD Million (2022-2027)
  • Table 407. Topical Drug Delivery Sales: by Type(K Units)
  • Table 408. Topical Drug Delivery Sales Skin Topical Drug Delivery  , by Region K Units (2022-2027)
  • Table 409. Topical Drug Delivery Sales Ophthalmic Topical Drug Delivery  , by Region K Units (2022-2027)
  • Table 410. Topical Drug Delivery Sales Rectal Topical Drug Delivery  , by Region K Units (2022-2027)
  • Table 411. Topical Drug Delivery Sales Vaginal Topical Drug Delivery  , by Region K Units (2022-2027)
  • Table 412. Topical Drug Delivery Sales Nasal Topical Drug Delivery , by Region K Units (2022-2027)
  • Table 413. Topical Drug Delivery Sales Others , by Region K Units (2022-2027)
  • Table 414. Topical Drug Delivery Sales: by Application(K Units)
  • Table 415. Topical Drug Delivery Sales Hospitals , by Region K Units (2022-2027)
  • Table 416. Topical Drug Delivery Sales Home Healthcare , by Region K Units (2022-2027)
  • Table 417. Topical Drug Delivery Sales Clinics , by Region K Units (2022-2027)
  • Table 418. Topical Drug Delivery Sales Diagnostic Centers , by Region K Units (2022-2027)
  • Table 419. Topical Drug Delivery Sales Others , by Region K Units (2022-2027)
  • Table 420. Topical Drug Delivery Sales: by Components(K Units)
  • Table 421. Topical Drug Delivery Sales Transdermal Drug Delivery Systems , by Region K Units (2022-2027)
  • Table 422. Topical Drug Delivery Sales Topical Drug Delivery Formulations , by Region K Units (2022-2027)
  • Table 423. Topical Drug Delivery Sales: by Form(K Units)
  • Table 424. Topical Drug Delivery Sales Creams , by Region K Units (2022-2027)
  • Table 425. Topical Drug Delivery Sales Gels , by Region K Units (2022-2027)
  • Table 426. Topical Drug Delivery Sales Powder , by Region K Units (2022-2027)
  • Table 427. Topical Drug Delivery Sales Skin Patches , by Region K Units (2022-2027)
  • Table 428. Topical Drug Delivery Sales Others , by Region K Units (2022-2027)
  • Table 429. South America Topical Drug Delivery Sales, by Country K Units (2022-2027)
  • Table 430. South America Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 431. South America Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 432. South America Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 433. South America Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 434. Brazil Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 435. Brazil Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 436. Brazil Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 437. Brazil Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 438. Argentina Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 439. Argentina Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 440. Argentina Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 441. Argentina Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 442. Rest of South America Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 443. Rest of South America Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 444. Rest of South America Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 445. Rest of South America Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 446. Asia Pacific Topical Drug Delivery Sales, by Country K Units (2022-2027)
  • Table 447. Asia Pacific Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 448. Asia Pacific Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 449. Asia Pacific Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 450. Asia Pacific Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 451. China Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 452. China Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 453. China Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 454. China Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 455. Japan Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 456. Japan Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 457. Japan Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 458. Japan Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 459. India Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 460. India Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 461. India Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 462. India Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 463. South Korea Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 464. South Korea Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 465. South Korea Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 466. South Korea Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 467. Taiwan Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 468. Taiwan Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 469. Taiwan Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 470. Taiwan Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 471. Australia Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 472. Australia Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 473. Australia Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 474. Australia Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 475. Rest of Asia-Pacific Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 476. Rest of Asia-Pacific Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 477. Rest of Asia-Pacific Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 478. Rest of Asia-Pacific Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 479. Europe Topical Drug Delivery Sales, by Country K Units (2022-2027)
  • Table 480. Europe Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 481. Europe Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 482. Europe Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 483. Europe Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 484. Germany Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 485. Germany Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 486. Germany Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 487. Germany Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 488. France Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 489. France Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 490. France Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 491. France Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 492. Italy Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 493. Italy Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 494. Italy Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 495. Italy Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 496. United Kingdom Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 497. United Kingdom Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 498. United Kingdom Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 499. United Kingdom Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 500. Netherlands Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 501. Netherlands Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 502. Netherlands Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 503. Netherlands Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 504. Rest of Europe Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 505. Rest of Europe Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 506. Rest of Europe Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 507. Rest of Europe Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 508. MEA Topical Drug Delivery Sales, by Country K Units (2022-2027)
  • Table 509. MEA Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 510. MEA Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 511. MEA Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 512. MEA Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 513. Middle East Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 514. Middle East Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 515. Middle East Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 516. Middle East Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 517. Africa Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 518. Africa Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 519. Africa Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 520. Africa Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 521. North America Topical Drug Delivery Sales, by Country K Units (2022-2027)
  • Table 522. North America Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 523. North America Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 524. North America Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 525. North America Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 526. United States Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 527. United States Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 528. United States Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 529. United States Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 530. Canada Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 531. Canada Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 532. Canada Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 533. Canada Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 534. Mexico Topical Drug Delivery Sales, by Type K Units (2022-2027)
  • Table 535. Mexico Topical Drug Delivery Sales, by Application K Units (2022-2027)
  • Table 536. Mexico Topical Drug Delivery Sales, by Components K Units (2022-2027)
  • Table 537. Mexico Topical Drug Delivery Sales, by Form K Units (2022-2027)
  • Table 538. Topical Drug Delivery: by Type(USD/Units)
  • Table 539. Research Programs/Design for This Report
  • Table 540. Key Data Information from Secondary Sources
  • Table 541. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Topical Drug Delivery: by Type USD Million (2016-2021)
  • Figure 5. Global Topical Drug Delivery: by Application USD Million (2016-2021)
  • Figure 6. Global Topical Drug Delivery: by Components USD Million (2016-2021)
  • Figure 7. Global Topical Drug Delivery: by Form USD Million (2016-2021)
  • Figure 8. South America Topical Drug Delivery Share (%), by Country
  • Figure 9. Asia Pacific Topical Drug Delivery Share (%), by Country
  • Figure 10. Europe Topical Drug Delivery Share (%), by Country
  • Figure 11. MEA Topical Drug Delivery Share (%), by Country
  • Figure 12. North America Topical Drug Delivery Share (%), by Country
  • Figure 13. Global Topical Drug Delivery: by Type K Units (2016-2021)
  • Figure 14. Global Topical Drug Delivery: by Application K Units (2016-2021)
  • Figure 15. Global Topical Drug Delivery: by Components K Units (2016-2021)
  • Figure 16. Global Topical Drug Delivery: by Form K Units (2016-2021)
  • Figure 17. South America Topical Drug Delivery Share (%), by Country
  • Figure 18. Asia Pacific Topical Drug Delivery Share (%), by Country
  • Figure 19. Europe Topical Drug Delivery Share (%), by Country
  • Figure 20. MEA Topical Drug Delivery Share (%), by Country
  • Figure 21. North America Topical Drug Delivery Share (%), by Country
  • Figure 22. Global Topical Drug Delivery: by Type USD/Units (2016-2021)
  • Figure 23. Global Topical Drug Delivery share by Players 2021 (%)
  • Figure 24. Global Topical Drug Delivery share by Players (Top 3) 2021(%)
  • Figure 25. Global Topical Drug Delivery share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2021
  • Figure 29. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 31. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Novartis International AG (Switzerland) Revenue: by Geography 2021
  • Figure 33. Galderma S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Galderma S.A. (Switzerland) Revenue: by Geography 2021
  • Figure 35. Bausch Health Companies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Bausch Health Companies Inc. (Canada) Revenue: by Geography 2021
  • Figure 37. Easton Pharmaceuticals, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Easton Pharmaceuticals, Inc. (Canada) Revenue: by Geography 2021
  • Figure 39. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 41. The 3M Company (United States) Revenue, Net Income and Gross profit
  • Figure 42. The 3M Company (United States) Revenue: by Geography 2021
  • Figure 43. Endo International plc (United States) Revenue, Net Income and Gross profit
  • Figure 44. Endo International plc (United States) Revenue: by Geography 2021
  • Figure 45. Crescita Therapeutics Inc (Canada) Revenue, Net Income and Gross profit
  • Figure 46. Crescita Therapeutics Inc (Canada) Revenue: by Geography 2021
  • Figure 47. MedPharm Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 48. MedPharm Ltd. (United Kingdom) Revenue: by Geography 2021
  • Figure 49. Catalent, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 50. Catalent, Inc. (United States) Revenue: by Geography 2021
  • Figure 51. Global Topical Drug Delivery: by Type USD Million (2022-2027)
  • Figure 52. Global Topical Drug Delivery: by Application USD Million (2022-2027)
  • Figure 53. Global Topical Drug Delivery: by Components USD Million (2022-2027)
  • Figure 54. Global Topical Drug Delivery: by Form USD Million (2022-2027)
  • Figure 55. South America Topical Drug Delivery Share (%), by Country
  • Figure 56. Asia Pacific Topical Drug Delivery Share (%), by Country
  • Figure 57. Europe Topical Drug Delivery Share (%), by Country
  • Figure 58. MEA Topical Drug Delivery Share (%), by Country
  • Figure 59. North America Topical Drug Delivery Share (%), by Country
  • Figure 60. Global Topical Drug Delivery: by Type K Units (2022-2027)
  • Figure 61. Global Topical Drug Delivery: by Application K Units (2022-2027)
  • Figure 62. Global Topical Drug Delivery: by Components K Units (2022-2027)
  • Figure 63. Global Topical Drug Delivery: by Form K Units (2022-2027)
  • Figure 64. South America Topical Drug Delivery Share (%), by Country
  • Figure 65. Asia Pacific Topical Drug Delivery Share (%), by Country
  • Figure 66. Europe Topical Drug Delivery Share (%), by Country
  • Figure 67. MEA Topical Drug Delivery Share (%), by Country
  • Figure 68. North America Topical Drug Delivery Share (%), by Country
  • Figure 69. Global Topical Drug Delivery: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • GlaxoSmithKline plc (United Kingdom)
  • Johnson & Johnson (United States)
  • Novartis International AG (Switzerland)
  • Galderma S.A. (Switzerland)
  • Bausch Health Companies Inc. (Canada)
  • Easton Pharmaceuticals, Inc. (Canada)
  • Bayer AG (Germany)
  • The 3M Company (United States)
  • Endo International plc (United States)
  • Crescita Therapeutics Inc (Canada)
  • MedPharm Ltd. (United Kingdom)
  • Catalent, Inc. (United States)
Additional players considered in the study are as follows:
Biofarmitalia s.r.l (Italy) , Mylan N.V (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 232 Pages 85 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Topical Drug Delivery Quantitative research analysis
Global Topical Drug Delivery Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Topical Drug Delivery Market are GlaxoSmithKline plc (United Kingdom), Johnson & Johnson (United States), Novartis International AG (Switzerland), Galderma S.A. (Switzerland), Bausch Health Companies Inc. (Canada), Easton Pharmaceuticals, Inc. (Canada), Bayer AG (Germany), The 3M Company (United States), Endo International plc (United States), Crescita Therapeutics Inc (Canada), MedPharm Ltd. (United Kingdom) and Catalent, Inc. (United States) etc.
The topical drug delivery is the application of formulations to the skin directly for the treatment of cutaneous disorders or manifestation of general disease. It is done with the intent confining the pharmacological effects of the drug within the skin or on the surface of the skin. The industrial sector for topical drug delivery is growing rapidly in addition to the established transdermal formulations by a large number of manufacturing companies. The global topical drug delivery market is constantly expanding throughout the world with a prevalence of skin-related diseases.

Know More About Global Topical Drug Delivery Report?

Have a Query? Click Here

Other Related Reports

Pediatric Drugs Comprehensive Study by Type (Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drug...
$ 3650
Soft Gelatin Capsules Comprehensive Study by Type (Gelatin, Non-Animal), Application (Pharmaceutical, Health Supplements, Others), Distribution Channel (Online, Offline), Outer Shell (Gelatin, Plasti...
$ 3350
Oral Thin Films Comprehensive Study by Type (Oromucosal, Orodispersible, • Orally Disintegrating, • Orally Dissolving), Application (Allergy/Cough and Cold, Pain Management, Anti-flatulence, Neurolog...
$ 3650
Animal Nutrition Comprehensive Study by Type (Minerals, Amino Acids, Vitamins, Enzymes, Others), Application (Poultry Feeds, Ruminant Feeds, Pig Feeds, Aquaculture Feeds, Others), Form (Dry, Liquid) ...
$ 3500
Compounding Pharmacies Comprehensive Study by Type (Oral Medication (Capsules, Tablets, Suspensions, Lozenges, and Others), Topical Medication (Creams, Gels, Ointments, and Others), Mouthwashes, Supp...
$ 3750
Vitamin B3 Comprehensive Study by Type (Pharmaceutical Grade, Feed Grade), Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals) Players and Region - Global...
$ 3500